Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Aniling

Aniling
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$732K LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of DNA sequencing methods designed to improve health care and prevent diseases. The company's DNA sequencing methods are used for applications regarding molecular data, genomics and epigenomics and also accelerate the discovery of new targets and mechanisms involved in diseases as cancer, diabetes or Alzheimer, enabling physicians and researchers to boost analysis, health care of human beings and get the most out of a DNA.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • IMPPC, Ctra Can Ruti
  • Camí de les Escoles s/n, Badalona
  • 08916 Barcelona
  • Spain

+34 935 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Aniling’s full profile, request a free trial.

Aniling Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 16-Oct-2018 $732K 00000 Completed Startup
1. Early Stage VC 17-Apr-2014 00000 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Aniling Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BAGi Angel Group Minority 000 0000 000000 0
Caixa Capital Risc Corporate Venture Capital 000 0000 000000 0

Aniling Executive Team (3)

Name Title Board
Seat
Contact
Info
Llorenç Coll Ph.D Chief Technology Officer, Co-Founder & Chief Executive Officer
Miguel Peinado Ph.D Co-Founder & Chief Scientific Officer
Jaume Amat Riera Strategic Avisor